doi: 10.3390/ijms25158214
Initial investigations into the cardiovascular safety effects of glucose-lowering medications in patients with T2D revealed an unexpected reduction in CV complications and mortality with the use glucagon-like peptide 1 receptor agonists (GLP1-RAs) and sodium-glucose cotransporter 2 inhibitors (SGLT2is)
Approval rates for tirzepatide PAs on TRICARE have not been publicly reported, but anecdotal data from military health system pharmacists suggest that requests with complete documentation and clear step therapy history receive approval at rates comparable to other specialty GLP-1 agents
Biological Age Is Not One Measurement Ageing research examines genomic stability, epigenetic changes, protein homeostasis, mitochondrial function, cellular senescence, immune ageing, stem-cell function and communication between tissues
Shop Jarrow Formulas S-Acetyl-L-Glutathione, an antioxidant to promote intracellular glutathione.*
BPC-157 does not develop traditional tolerance since it operates non-hormonally and does not suppress natural production